SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma
Xi Zhang(Shanghai Institute of Materia Medica), Linghua Meng(Shanghai Institute of Materia Medica)
Cited by 11
Related Papers
Xanthine dehydrogenase rewires metabolism and the survival of nutrient deprived lung adenocarcinoma cells by facilitating UPR and autophagic degradation
|International Journal of Biological Sciences|2023|19
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors
|Signal Transduction and Targeted Therapy|2023|15
Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3Kα-selective Inhibitors in Breast Cancer
|Theranostics|2017|14
PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors
|Cell Death and Disease|2025|4